scholarly article | Q13442814 |
P50 | author | Fabiana Kömmling Seixas | Q59676157 |
Sílvia Stanisçuaski Guterres | Q89805492 | ||
Mariana H Remião | Q114521729 | ||
Natalia V Segatto | Q117276057 | ||
Adriana R. Pohlmann | Q39026542 | ||
Tiago Collares | Q42913125 | ||
P2860 | cites work | Ultrasensitive amperometric immunosensor for PSA detection based on Cu2O@CeO2-Au nanocomposites as integrated triple signal amplification strategy | Q49051876 |
Nanoincorporation of bioactive compounds from red grape pomaces: In vitro and ex vivo evaluation of antioxidant activity. | Q50205295 | ||
Melatonin promotes the in vitro development of pronuclear embryos and increases the efficiency of blastocyst implantation in murine. | Q50738597 | ||
Transplantation of testicular tissue in alginate hydrogel loaded with VEGF nanoparticles improves spermatogonial recovery. | Q50852302 | ||
CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes | Q22337358 | ||
Potential toxicity of engineered nanoparticles in mammalian germ cells and developing embryos: treatment strategies and anticipated applications of nanoparticles in gene delivery | Q26744195 | ||
In vitro maturation of human oocytes: Its role in infertility treatment and new possibilities | Q26822425 | ||
Extracellular vesicle-mediated delivery of molecular compounds into gametes and embryos: learning from nature | Q28083833 | ||
Transfer of Silver Nanoparticles through the Placenta and Breast Milk during in vivo Experiments on Rats | Q28392147 | ||
Damaging effects of multi-walled carbon nanotubes on pregnant mice with different pregnancy times | Q28397478 | ||
Effects of Two Types of Melatonin-Loaded Nanocapsules with Distinct Supramolecular Structures: Polymeric (NC) and Lipid-Core Nanocapsules (LNC) on Bovine Embryo Culture Model | Q28550292 | ||
Color Tunable Gd-Zn-Cu-In-S/ZnS Quantum Dots for Dual Modality Magnetic Resonance and Fluorescence Imaging | Q30875682 | ||
Generation of superparamagnetic liposomes revealed as highly efficient MRI contrast agents for in vivo imaging | Q30996711 | ||
Gene therapy of endometriosis introduced by polymeric micelles with glycolipid-like structure | Q31034853 | ||
Construction of magnetic-carbon-quantum-dots-probe-labeled apoferritin nanocages for bioimaging and targeted therapy | Q31132658 | ||
Alterations of expression of developmentally important genes in preimplantation bovine embryos by in vitro culture conditions: implications for subsequent development | Q33873849 | ||
Self-assembled DNA nanoclews for the efficient delivery of CRISPR-Cas9 for genome editing. | Q34044724 | ||
Magnetically triggered drug release from nanoparticles and its applications in anti-tumor treatment. | Q50902633 | ||
Cationic dendritic starch as a vehicle for photodynamic therapy and siRNA co-delivery. | Q50990014 | ||
Reproductive medicine involving genome editing: clinical uncertainties and embryological needs. | Q51137943 | ||
Biosensor based on a silicon nanowire field-effect transistor functionalized by gold nanoparticles for the highly sensitive determination of prostate specific antigen. | Q51182793 | ||
Enhanced Cytotoxicity of Folic Acid-Targeted Liposomes Co-Loaded with C6 Ceramide and Doxorubicin: In Vitro Evaluation on HeLa, A2780-ADR, and H69-AR Cells. | Q52892926 | ||
Development and pharmacological evaluation of in vitro nanocarriers composed of lamellar silicates containing copaiba oil-resin for treatment of endometriosis. | Q53111974 | ||
Distribution and accumulation of 10 nm silver nanoparticles in maternal tissues and visceral yolk sac of pregnant mice, and a potential effect on embryo growth. | Q53268705 | ||
Multiplexed magnetic nanoparticle-antibody conjugates (MNPs-ABS) based prognostic detection of ovarian cancer biomarkers, CA-125, β-2M and ApoA1 using fluorescence spectroscopy with comparison of surface plasmon resonance (SPR) analysis. | Q53473140 | ||
An ultra-sensitive impedimetric immunosensor for detection of the serum oncomarker CA-125 in ovarian cancer patients | Q57123380 | ||
Elective single embryo transfer in women less than age 38 years reduces multiple birth rates, but not live birth rates, in United States fertility clinics | Q64124403 | ||
Pregnancies after co-culture of cumulus cells with bovine embryos derived from in-vitro fertilization of in-vitro matured follicular oocytes | Q68490227 | ||
Blastocyst stage transfer: pitfalls and benefits. Too soon to abandon current practice? | Q77787756 | ||
In vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice | Q81697594 | ||
Multiplexed DNA detection with biobarcoded nanoparticle probes | Q83121539 | ||
NanoSMGT: transgene transmission into bovine embryos using halloysite clay nanotubes or nanopolymer to improve transfection efficiency | Q84625405 | ||
Preimplantation genetic diagnosis and screening: Current status and future challenges | Q47956951 | ||
Facial Layer-by-Layer Engineering of Upconversion Nanoparticles for Gene Delivery: Near-Infrared-Initiated Fluorescence Resonance Energy Transfer Tracking and Overcoming Drug Resistance in Ovarian Cancer | Q48047850 | ||
Predictive factors for live birth after in vitro maturation of oocytes in women with polycystic ovary syndrome. | Q48218793 | ||
High doses of lipid-core nanocapsules do not affect bovine embryonic development in vitro | Q48512747 | ||
Patient and cycle characteristics predicting high pregnancy rates with single-embryo transfer: an analysis of the Society for Assisted Reproductive Technology outcomes between 2004 and 2013. | Q48512764 | ||
BPA exposure during in vitro oocyte maturation results in dose-dependent alterations to embryo development rates, apoptosis rate, sex ratio and gene expression | Q48561471 | ||
Exogenous DNA uptake of boar spermatozoa by a magnetic nanoparticle vector system | Q48712741 | ||
Development of hatching blastocysts from immature human oocytes following in-vitro maturation and fertilization using a co-culture system | Q48932526 | ||
To blastocyst or not to blastocyst? That is the question | Q34201733 | ||
Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome. | Q34356904 | ||
Cumulative live birth rate and assisted reproduction: impact of female age and transfer day. | Q34439758 | ||
Melatonin improves the quality of in vitro produced (IVP) bovine embryos: implications for blastocyst development, cryotolerance, and modifications of relevant gene expression | Q35138531 | ||
Downregulation of DNA methyltransferase 1 in zona-free cloned buffalo (Bubalus bubalis) embryos by small interefering RNA improves in vitro development but does not alter DNA methylation level. | Q35230722 | ||
Age-Related Success with Elective Single versus Double Blastocyst Transfer | Q35608871 | ||
Hyaluronic acid reagent functional chitosan-PEI conjugate with AQP2-siRNA suppressed endometriotic lesion formation | Q35995453 | ||
Detection of serum human epididymis secretory protein 4 in patients with ovarian cancer using a label-free biosensor based on localized surface plasmon resonance | Q36058736 | ||
Multiple birth resulting from ovarian stimulation for subfertility treatment | Q36135826 | ||
Evaluation of PLGA containing anti-CTLA4 inhibited endometriosis progression by regulating CD4+CD25+Treg cells in peritoneal fluid of mouse endometriosis model | Q36227541 | ||
Quantitative [Fe]MRI of PSMA-targeted SPIONs specifically discriminates among prostate tumor cell types based on their PSMA expression levels | Q36498760 | ||
Oxidative stress in an assisted reproductive techniques setting | Q36543894 | ||
Future lab-on-a-chip technologies for interrogating individual molecules | Q36548311 | ||
Gene Therapy of the β-Hemoglobinopathies by Lentiviral Transfer of the β(A(T87Q))-Globin Gene | Q36654528 | ||
Part II: coordinated biosensors--development of enhanced nanobiosensors for biological and medical applications | Q36988333 | ||
Assisted reproductive technologies and pregnancy outcomes: mechanistic insights from animal studies | Q37095414 | ||
Assessing Therapeutic Potential of Magnetic Mesoporous Nanoassemblies for Chemo-Resistant Tumors. | Q37112958 | ||
Magnetic nanoparticles as a new approach to improve the efficacy of gene therapy against differentiated human uterine fibroid cells and tumor-initiating stem cells | Q37148646 | ||
Preparation, characterization, and transport of dexamethasone-loaded polymeric nanoparticles across a human placental in vitro model | Q37238557 | ||
Nanoparticle-based bio-barcode assay redefines "undetectable" PSA and biochemical recurrence after radical prostatectomy | Q37413491 | ||
Different effects of the immunomodulatory drug GMDP immobilized onto aminopropyl modified and unmodified mesoporous silica nanoparticles upon peritoneal macrophages of women with endometriosis. | Q37448466 | ||
Iron oxide nanoparticle encapsulated diatoms for magnetic delivery of small molecules to tumors | Q37682638 | ||
Current and future prospects for nanotechnology in animal production | Q37700803 | ||
Ovarian hyperstimulation syndrome prevention strategies: in vitro maturation | Q37820952 | ||
In vitro fertilisation: perinatal risks and early childhood outcomes | Q38011264 | ||
Nanotechnology in reproductive medicine: emerging applications of nanomaterials | Q38180226 | ||
Behaviour of cytoplasmic organelles and cytoskeleton during oocyte maturation | Q38180264 | ||
Gold nanoparticles as contrast agents in x-ray imaging and computed tomography. | Q38324026 | ||
Bovine in vitro reproduction models can contribute to the development of (female) fertility preservation strategies | Q38485559 | ||
Nanomedicine and mammalian sperm: Lessons from the porcine model | Q38538789 | ||
Application of nanomaterials in the bioanalytical detection of disease-related genes | Q38541777 | ||
Advances in Gene Therapy for Haemophilia | Q38611429 | ||
Graphene oxide layer decorated gold nanoparticles based immunosensor for the detection of prostate cancer risk factor | Q38633363 | ||
Gene therapy for inherited retinal degenerations: initial successes and future challenges. | Q38638775 | ||
Propensity score-matched study and meta-analysis of cumulative outcomes of day 2/3 versus day 5/6 embryo transfers | Q38661052 | ||
Active targeting co-delivery system based on hollow mesoporous silica nanoparticles for antitumor therapy in ovarian cancer stem-like cells | Q38668351 | ||
Improved quality of porcine embryos cultured with hyaluronan due to the modification of the mitochondrial membrane potential and reactive oxygen species level | Q38679071 | ||
Nanoparticle delivery of siRNA against TWIST to reduce drug resistance and tumor growth in ovarian cancer models. | Q38728683 | ||
A 'degradable' poly(vinyl alcohol) iron oxide nanoparticle hydrogel | Q38788836 | ||
Pharmacokinetics of Chiral Dendrimer-Triamine-Coordinated Gd-MRI Contrast Agents Evaluated by in Vivo MRI and Estimated by in Vitro QCM. | Q38809792 | ||
Long-Term Retrospective Analysis of Gene Therapy with Alipogene Tiparvovec and Its Effect on Lipoprotein Lipase Deficiency-Induced Pancreatitis | Q38895774 | ||
Nanotechnologies in delivery of mRNA therapeutics using nonviral vector-based delivery systems | Q39091854 | ||
Dimeric gold nanoparticle assemblies as tags for SERS-based cancer detection | Q39180840 | ||
Recent Advances in Nanomaterials for Gene Delivery-A Review | Q39269584 | ||
Mitigation of endometriosis using regenerative cerium oxide nanoparticles. | Q39283010 | ||
Electrochemical immunosensor based on ZnO nanorods-Au nanoparticles nanohybrids for ovarian cancer antigen CA-125 detection | Q39291147 | ||
Carbosilane dendrimer nanotechnology outlines of the broad HIV blocker profile. | Q39339007 | ||
Nanoparticles-in-film for the combined vaginal delivery of anti-HIV microbicide drugs | Q39355306 | ||
In vivo toxicological evaluation of polymeric nanocapsules after intradermal administration. | Q39424873 | ||
The International Glossary on Infertility and Fertility Care, 2017. | Q39623657 | ||
Antioxidants improve mouse preimplantation embryo development and viability | Q39777478 | ||
Silver nanoparticles inhaled during pregnancy reach and affect the placenta and the foetus | Q40158582 | ||
Assessment of nuclear and cytoplasmic maturation in in-vitro matured human oocytes | Q40649413 | ||
Effect of Nanoparticles on the Survival and Development of Vitrified Porcine GV Oocytes | Q41597650 | ||
Effect of resveratrol supplementation during culture on the quality and cryotolerance of bovine in vitro produced embryos. | Q41601897 | ||
A "freeze-all" embryo strategy after in vitro maturation: a novel approach in women with polycystic ovary syndrome? | Q41604137 | ||
Comparison of fetal toxicity of various multi-wall carbon nanotubes in mice | Q41680094 | ||
Nuclear and cytoplasmic determinants involved in the regulation of mammalian oocyte maturation | Q41724621 | ||
Multiwall carbon nanotubes as MRI contrast agents for tracking stem cells. | Q42048310 | ||
Melatonin delivery by nanocapsules during in vitro bovine oocyte maturation decreased the reactive oxygen species of oocytes and embryos. | Q42696620 | ||
Tretinoin-loaded lipid-core nanocapsules decrease reactive oxygen species levels and improve bovine embryonic development during in vitro oocyte maturation. | Q42700343 | ||
Oxidative status in granulosa cells of infertile women undergoing IVF. | Q43834526 | ||
Electrochemical Genosensor Based on Colloidal Gold Nanoparticles for the Detection of Factor V Leiden Mutation Using Disposable Pencil Graphite Electrodes | Q44421745 | ||
Temporal divergence in the pattern of messenger RNA expression in bovine embryos cultured from the zygote to blastocyst stage in vitro or in vivo. | Q44491382 | ||
Correction of a pathogenic gene mutation in human embryos | Q45370513 | ||
Effects of mesoporous silica nanoparticles upon the function of mammalian sperm in vitro | Q45857858 | ||
Gene therapy for Wiskott-Aldrich syndrome in a severely affected adult | Q45869832 | ||
Nanoparticle-in-gel system for delivery of vitamin C for topical application | Q46353750 | ||
Modified PVA-Fe3O4 nanoparticles as protein carriers into sperm cells | Q46446171 | ||
Oxidative stress impairs oocyte quality and melatonin protects oocytes from free radical damage and improves fertilization rate | Q46703449 | ||
L-carnitine decreases DNA damage and improves the in vitro blastocyst development rate in mouse embryos | Q46772129 | ||
A liposomal nanoscale contrast agent for preclinical CT in mice. | Q46901989 | ||
Nanoparticle-Assisted Combinatorial Therapy for Effective Treatment of Endometriosis. | Q47616630 | ||
Biocompatibility assessment of titanium dioxide nanoparticles in mice fetoplacental unit | Q47700745 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P921 | main subject | nanotechnology | Q11468 |
P304 | page(s) | 994 | |
P577 | publication date | 2017-01-01 | |
P1433 | published in | Frontiers in Pharmacology | Q2681208 |
P1476 | title | The Potential of Nanotechnology in Medically Assisted Reproduction | |
P478 | volume | 8 |
Search more.